Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity
DESCRIPTION:
The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of 3 or more points at a follow up visit.
| MEASURE ID: | 485 |
|---|---|
| Type: | Patient-Reported Outcome |
CMS Derm Specialty Set: | Yes |
| High priority: | Yes |
| Topped out: | No |
| Telehealth Eligible: | Yes |
| Reporting methods: | Registry/QCDR |
| Maximum points: | 10 |
MEASURE PURPOSE:
This measure aims to improve pruritus in psoriasis patients in which symptoms are very burdensome; by assessing itch, aiming to make the symptom more manageable, and improving overall disease/response.
Measure 485 FAQs
Q. Is this measure reportable via claims?
A. No.
Q. Are patient encounters conducted via telehealth allowable?
A. Yes. Encounters coded with GQ, GT, POS 02, or POS 10 modifiers are allowable.
Q. What is the numerator?
A. The numerator are patients who achieve an assessment score that is reduced by 3 or more points from the initial (index) assessment score.
Q. What is the denominator?
A. The denominator are patients aged 8 years and older, with a diagnosis of psoriasis with an initial (index visit) NRS, VRS, or ItchyQuant assessment score of greater than or equal to 4 who are returning for a follow-up visit.
Q. Are there any exceptions for this measure?
A. No.
Q. If a patient does not have an initial NRS of greater than or equal to 4, are they supposed to be counted as an eligible patient as an exception?
A. If the patient does not have an initial score of 4 or more, then they are not denominator eligible and are not applicable to the measure.
Q. Where can I find more information about licensing the ItchyQuant tool?
Calculation
The numerator: Patients who achieve an assessment score that is reduced by 3 or more points (minimal clinically important difference) from the initial (index) assessment score
The denominator: All patients aged 8 years and older, with a diagnosis of psoriasis with an initial (index visit) NRS, VRS, or ItchyQuant assessment score of greater than or equal to 4 who are returning for a follow-up visit.
Measure calculation example
Dr. Smith saw 100 adult patients return for a follow-up visit who have psoriasis during the reporting period. Of those, 89 patients had an initial visit where their itch assessment score was 4 or greater. Eighty-nine (89) is the denominator.
A total of 81 patients completed the itch severity assessment and of those 74 had a score reduction of 3 or more points. Seventy-four (74) is the numerator.
Quality of patient care = 74/89. Dr. Smith has a score of 83.1% for this measure. This translates to 9 to 9.9 points.
Important note
Because of how this measure is structured, physicians score 3 points even if they report on only one patient. This is applicable only to small practices with 15 providers or fewer. A score of 96.30% and above earns 10 points.
Quality measure score benchmark
CMS will award points based on a comparison of your performance rate to CMS benchmarks listed below. Reach the performance rate listed to achieve the corresponding points per measure. Points achieved for the Quality category will account for 30% of the overall MIPS score.
| Decile 1 | Decile 2 | Decile 3 | Decile 4 | Decile 5 | Decile 6 | Decile 7 | Decile 8 | Decile 9 | Decile 10 |
|---|---|---|---|---|---|---|---|---|---|---|
Performance rate |
3.45 - 19.99 |
20.00 - 29.06 |
29.07 - 36.67 |
36.68 - 42.85 |
42.86 - 49.30 |
49.31 - 55.16 |
55.17 - 64.28 |
64.29 - 76.91 |
76.92 - 96.29 |
>=96.30 |
Points |
1.0 - 1.9 |
2.0 - 2.9 |
3.0 - 3.9 |
4.0 - 4.9 |
5.0 - 5.9 |
6.0 - 6.9 |
7.0 - 7.9 |
8.0 - 8.9 |
9.0 - 9.9 |
10 |
